{
  "id": 4604,
  "text": "</td><td>Good practice statement </td><td>34.As programmes introduce HPV DNA testing, use this test at the woman's next routine screening date regardless of the test that was used at prior screening.In existing programmes with cytology or VIA as the primary screening test, rescreening with the same test should be continued until HPV DNA testing is operational among both the general population of women and women living with HIV.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: </td><td>Good practice statement </td><td>34.As programmes introduce HPV DNA testing, use this test at the woman's next routine screening date regardless of the test that was used at prior screening.In existing programmes with cytology or VIA as the primary screening test, rescreening with the same test should be continued until HPV DNA testing is operational among both the general population of w\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在现有的宫颈癌筛查项目中，如果需要引入HPV DNA检测，应在妇女下一个常规筛查日期直接使用该检测方法，而不必考虑之前使用的是哪种检测方法。在目前仍以细胞学筛查或醋酸浸润检查（VIA）为主要筛查手段的项目中，建议继续使用原筛查方法进行复查，直到HPV DNA检测在普通妇女群体和HIV感染妇女群体中全面投入使用为止。这可以确保筛查方法间的平稳过渡并维持筛查的有效性和覆盖面。",
  "query": "**在现有的宫颈癌筛查项目中，如需引入HPV DNA检测，应如何处理之前使用其他检测方法筛查过的妇女？**",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: **在现有的宫颈癌筛查项目中，如需引入HPV DNA检测，应如何处理之前使用其他检测方法筛查过的妇女？**\n\n<reference text>: </td><td>Good practice statement </td><td>34.As programmes introduce HPV DNA testing, use this test at the woman's next routine screening date regardless of the test that was used at prior screening.In existing programmes with cytology or VIA as the primary screening test, rescreening with the same test should be continued until HPV DNA testing is operational among both the general population of women and women living with HIV.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在现有的宫颈癌筛查项目中，如果需要引入HPV DNA检测，应在妇女下一个常规筛查日期直接使用该检测方法，而不必考虑之前使用的是哪种检测方法。在目前仍以细胞学筛查或醋酸浸润检查（VIA）为主要筛查手段的项目中，建议继续使用原筛查方法进行复查，直到HPV DNA检测在普通妇女群体和HIV感染妇女群体中全面投入使用为止。这可以确保筛查方法间的平稳过渡并维持筛查的有效性和覆盖面。"
}